We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




A Miniature Mechanical Pump Helps Weak Hearts

By HospiMedica staff writers
Posted on 05 May 2008
An implantable left ventricular assist system (LVAS) sustains patients awaiting heart transplant, gives them a better quality of life, and improved chances of survival.

The HeartMateII LVAS the HeartMate II is intended for left, right, and biventricular support for bridge-to-heart transplantation and for post-cardiotomy recovery. More...
The device provides continuous blood flow through the circulatory system using only one moving part - a rotary pumping mechanism. At the heart of the system pump is a flattened titanium cylinder about five cm thick and 10 cm in circumference, and weighing 1.2 kg. The pump has two chambers: a blood chamber and a motor chamber. A flexible membrane separates the two, which moves up and down when pushed by the motor. The inside of the pump is made of beaded titanium, which creates a rough, textured surface. The other side is made of textured polyurethane, which helps the body form a lining inside the pump, mimicking the blood vessels. The HeartMate pump contains unidirectional valves that allow the blood flow only from the left ventricle through the pump and out to the body. The HeartMate can pump up to 10 liters per minute.

The system includes the implantable heart pump and a driveline that connects it to the system controller. The system also includes a power base unit (PB), used for charging batteries and for powering the pump while the patient is at rest, and a display module to show pump information. The device has been designed to be quieter and more durable than most other pumps, and is only one-eighth the size of the original HeartMate LVAS. The HeartMate II is manufactured by Thoratec (Pleasanton, CA, USA), and has been approved by the U.S. Food and Drug Administration (FDA).

"For patients whose hearts are unable to effectively pump blood due to severe heart failure, this remarkable device can help them have active lives as they await a heart transplant,” said Dr. Yoshifumi Naka, M.D., director of cardiac transplantation at NewYork-Presbyterian Hospital/Columbia University Medical Center (New York, NY, USA) and associate professor of surgery at Columbia University College of Physicians and Surgeons (New York, NY, USA).


Related Links:
Thoratec
NewYork-Presbyterian Hospital/Columbia University Medical Center

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Absorbable Monofilament Mesh
Phasix Mesh
Mammo DR Retrofit Solution
DR Retrofit Mammography
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.